IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance

PR Newswire01:00

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Tech-Driven Gains Falter at Year-End

MT Newswires2024/12/30 22:02

IDEAYA Biosciences Enters Into Licensing Agreement With Jiangsu Hengrui for Cancer Drug Candidate SHR-4849

MT Newswires2024/12/30 17:34

Reported Sunday, IDEAYA Biosciences Secures Global License For SHR-4849, A Novel Phase 1 DLL3-Targeting ADC For SCLC And NET Tumors

Benzinga2024/12/30 15:33

突发！这家公司及实控人因涉嫌信披违法违规被证监会立案|盘后公告集锦

cls.cn2024/12/29 18:34

恒瑞医药(600276.SH)：与IDEAYA Biosciences签署SHR-4849项目授权许可协议

Gelonghui Finance2024/12/29 16:45